elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Testosterone (patch)
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Testosterone (patch)
RIS
0.001
(Research Intensity Score)
Papers
148
Top papers
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
2017 · 1786 citations
Recent Advances in the Management of Metastatic Prostate Cancer
2021 · 146 citations
Effects of cigarette smoking on semen quality, reproductive hormone levels, metabolic profile, zinc and sperm DNA fragmentation in men: results from a population-based study
2023 · 54 citations
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial
2024 · 49 citations
Association between Prenatal Exposure to PFAS and Fetal Sex Hormones: Are the Short-Chain PFAS Safer?
2020 · 150 citations
Newest papers
Alpha-ketoglutarate alleviates Cadmium-induced ferroptosis in association with enhanced mitochondrial function in testes
2026 · 1 citations
Impact of Cadmium Toxicity on Testicular Function: Risk of Male Infertility
2026 · 2 citations
From therapeutic benefit to cardiovascular risk: a multidisciplinary review on anabolic steroids
2026
Muscle & Bone Health After 40
2026
DIETARY AQUEOUS GARLIC (ALLIUM SATIVUM) SUPPLEMENTATION MODULATES REPRODUCTIVE HORMONAL PROFILES IN NIGERIAN INDIGENOUS COCKS
2026
A sample from the 100 top papers behind Testosterone (patch).
Create a free account to browse them all →
Testosterone (patch)'s history
Research intensity over time
Explore Testosterone (patch)'s full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Testosterone (patch)'s papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link